Management

Management

 

BioPhero was founded by Dr. Irina Borodina as a technology spin-out from the Technical University of Denmark in 2016. The purpose was to commercialise novel technology for production of pheromones.

BioPhero is located in Copenhagen, Denmark.

 

 

 

Leadership

Dr. Irina Borodina, CSO & Co-Founder

Irina Borodina holds a Ph.D. in Biotechnology from the Technical University of Denmark.

Irina is an entrepreneur and scientist with extensive experience in the development of yeast-based fermentation platforms. Irina founded BioPhero in 2016 based on research within yeast-based pheromone production. She also heads a research group at the Novo Nordisk Foundation Center for Biosustainability, which focuses on metabolic engineering of yeast cell factories for bio-sustainable production of chemicals from renewable feedstocks.

Mr. Kristian Ebbensgaard, CEO

Kristian Ebbensgaard holds an M.Sc. Econ. from the Copenhagen Business School.

Kristian has experience in the fields of business management and new business development. He has lived and worked in Denmark, France, Switzerland and India. Kristian has experience with commercial management and business development of global biotechnology markets in several industries including food, beverage alcohol as well as pulp and paper. His experience includes a decade in senior roles at Novozymes.

Mr. Mikael Bechsgaard, CFO/CMO

Mikael Bechsgaard holds a M.Sc. Econ. from the Copenhagen Business School, an executive leadership education from INSEAD and part-time chemistry studies.

Mikael has a versatile background, having worked in IT start-up, management consultancy and 15 years in industrial biotech. In biotech he has held several senior commercial leadership positions in global purchasing, sales and marketing in household care and digital transformation. Mikael compares his career with a triathlon – training one discipline will benefit the others. At BioPhero, he is putting all the disciplines together.

Dr. Jesper Dohrup, CTO

Jesper Dohrup holds a Ph.D. in chemistry from the Technical University of Denmark.

Jesper is an experienced commercial manager and industrial process engineer with extensive experience in industrial biomass processing and biorefineries from start-up to commercial take-off.

Board of Directors

Mr. Hadyn Parry

Chairman

Hadyn Parry is an experienced executive from the biotechnology, life science, and agro-chemical industries.

He has experience with building new companies from his time as CEO of Oxitec –the world's first company to use genetically engineered male insects to combat mosquitoes that spread damaging diseases (such as Dengue Fever and Zika virus) and major pests of agricultural crops.

Dr. John Hamer

Board Member, DCVC Bio

John is a Managing Partner at DCVC Bio. Prior to joining DCVC, John was a VP at Monsanto and Managing Director of Monsanto Growth Ventures (MGV). Before joining MGV, John was a Managing Director at Burrill & Company. Prior to his career in venture capital, John was an entrepreneur, initially at Paradigm Genetics, where he joined as a visiting scientist before becoming Chief Science Officer and eventually President and CEO following the company’s IPO. After Paradigm, John founded and served as CEO of Arête Therapeutics, which earned backing from leading life science venture firms.

Dr. Michael Lee

Board Member, Syngenta Group Ventures

Michael Lee holds a B.Sc. in Zoology and a Ph.D. in insect biochemistry from the University of Durham.

Michael joined Syngenta Group Ventures in 2013, and spent several years at Unilever’s corporate venturing group based in the US and UK investing in early stage companies. Michael is a Fellow of the Royal Entomological Society and has published several scientific papers about insects.

Dr. Thomas Grotkjær

Board Member, Novo Seeds

Thomas holds an MSc in chemical engineering and a PhD in metabolic engineering and bioinformatics from the Technical University of Denmark.

Thomas joined Novo Seeds in 2017 focusing on investments in industrial biotechnology. Thomas has business and R&D experience from Novozymes, Fluxome, Carlsberg, and BASF.

Advisory Board

Charlotte Vedel

Area of expertise: Intellectual property COO and co-founder of biotech startup Lactobio Previously: VP IP and IP Strategy at DuPont

Jesper Haugaard

Area of expertise: Large-scale industrial fermentation and processes Vice President, EMA Operations, Novozymes